| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1127684773 |
| P356 | DOI | 10.1007/S10989-020-10072-0 |
| P932 | PMC publication ID | 7233194 |
| P698 | PubMed publication ID | 32427225 |
| P50 | author | Reema Gabrani | Q90581202 |
| P2093 | author name string | Garima Agarwal | |
| P2860 | cites work | In vitro antiviral activity of antimicrobial peptides against herpes simplex virus 1, adenovirus, and rotavirus | Q40110984 |
| Broad-spectrum antiviral therapeutics | Q21135293 | ||
| Antiviral activities of lactoferrin | Q24457223 | ||
| Characterizing the anti-HIV activity of papuamide A | Q24645399 | ||
| Perspective of Use of Antiviral Peptides against Influenza Virus | Q26780434 | ||
| Antiviral Peptides Targeting the West Nile Virus Envelope Protein | Q27478055 | ||
| RETRACTED: Selection of cyclic peptide aptamers to HCV IRES RNA using mRNA display | Q27486984 | ||
| Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3 | Q28117302 | ||
| Cytolytic nanoparticles attenuate HIV-1 infectivity | Q28274397 | ||
| Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries | Q28343374 | ||
| Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37 | Q28477585 | ||
| Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7 | Q28482446 | ||
| Structural and functional characterization of a multifunctional alanine-rich peptide analogue from Pleuronectes americanus | Q28484282 | ||
| Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses. | Q30374098 | ||
| Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2. | Q30377821 | ||
| Natural Products as Promising Therapeutics for Treatment of Influenza Disease. | Q30379855 | ||
| Novel peptides that inhibit the propagation of Newcastle disease virus | Q31059576 | ||
| Practical tips for construction of custom Peptide libraries and affinity selection by using commercially available phage display cloning systems | Q31093549 | ||
| Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase | Q31155662 | ||
| Microspinosamide, a new HIV-inhibitory cyclic depsipeptide from the marine sponge Sidonops microspinosa | Q31917413 | ||
| Selection of high affinity ligands to hepatitis B core antigen from a phage-displayed cyclic peptide library | Q33185184 | ||
| Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase | Q33207804 | ||
| Identification of a novel B cell epitope on the nucleocapsid protein of porcine reproductive and respiratory syndrome virus by phage display | Q33217422 | ||
| Identification and characterization of peptides binding to newcastle disease virus by phage display | Q33231053 | ||
| Identification of one peptide which inhibited infectivity of avian infectious bronchitis virus in vitro | Q33243606 | ||
| Selection of a phage-displayed peptide recognized by monoclonal antibody directed blocking the site of hepatitis C virus E2 for human CD81. | Q33267038 | ||
| Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site | Q33267760 | ||
| Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target | Q33275939 | ||
| Mollamides B and C, Cyclic hexapeptides from the indonesian tunicate Didemnum molle | Q33342365 | ||
| Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library | Q33475044 | ||
| Mutremdamide A and koshikamides C-H, peptide inhibitors of HIV-1 entry from different Theonella species | Q33558877 | ||
| Functional selection of hepatitis C virus envelope E2-binding Peptide ligands by using ribosome display | Q33579851 | ||
| A new natural α-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV. | Q33720059 | ||
| Ribosome display: a technology for selecting and evolving proteins from large libraries | Q33725795 | ||
| Biosensor-based small molecule fragment screening with biolayer interferometry. | Q33928781 | ||
| Advantages of mRNA display selections over other selection techniques for investigation of protein-protein interactions | Q33934415 | ||
| Identification of two linear B-cell epitopes from West Nile virus NS1 by screening a phage-displayed random peptide library | Q33951093 | ||
| Neamphamide A, a new HIV-inhibitory depsipeptide from the Papua New Guinea marine sponge Neamphius huxleyi | Q33980910 | ||
| Blocking peptides against HBV: preS1 protein selected from a phage display library | Q33998309 | ||
| Phage displayed peptides to avian H5N1 virus distinguished the virus from other viruses | Q34009244 | ||
| mRNA display-based selections using synthetic peptide and natural protein libraries | Q34077298 | ||
| Antiviral and antitumor peptides from insects. | Q34188871 | ||
| Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro | Q34320261 | ||
| A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein | Q34328401 | ||
| Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro | Q34379985 | ||
| Potential of peptides as inhibitors and mimotopes: selection of carbohydrate-mimetic peptides from phage display libraries | Q34456700 | ||
| Selection of antiviral peptides against mink enteritis virus using a phage display Peptide library | Q34511916 | ||
| An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses | Q34555441 | ||
| Surface Plasmon Resonance: An Introduction to a Surface Spectroscopy Technique | Q34607295 | ||
| Mirabamides A-D, depsipeptides from the sponge Siliquariaspongia mirabilis that inhibit HIV-1 fusion | Q34707103 | ||
| Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity | Q34758057 | ||
| Mirabamides E-H, HIV-inhibitory depsipeptides from the sponge Stelletta clavosa | Q34769803 | ||
| A peptide inhibitor of cytomegalovirus infection from human hemofiltrate | Q34821852 | ||
| Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities | Q35085127 | ||
| Identification of peptides that bind hepatitis C virus envelope protein E2 and inhibit viral cellular entry from a phage-display peptide library | Q35103553 | ||
| Identification of natural antimicrobial agents to treat dengue infection: In vitro analysis of latarcin peptide activity against dengue virus | Q35178461 | ||
| Selection of peptide mimics of HIV-1 epitope recognized by neutralizing antibody VRC01. | Q35191547 | ||
| Specific ligands for classical swine fever virus screened from landscape phage display library | Q35197772 | ||
| Reverse Engineering of Vaccine Antigens Using High Throughput Sequencing-enhanced mRNA Display | Q35794740 | ||
| Stellettapeptins A and B, HIV-inhibitory cyclic depsipeptides from the marine sponge Stelletta sp. | Q35795268 | ||
| Kinetic characterization of trans-proteolytic activity of Chikungunya virus capsid protease and development of a FRET-based HTS assay | Q35800438 | ||
| Anti-microbial peptides: from invertebrates to vertebrates. | Q35806874 | ||
| Unusual Biosynthesis and Structure of Locillomycins from Bacillus subtilis 916 | Q36033311 | ||
| Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo | Q36216315 | ||
| Phage-displayed peptide targeting on the Puumala hantavirus neutralization site | Q36852841 | ||
| Cyclotides as natural anti-HIV agents. | Q37002917 | ||
| Celebesides A-C and theopapuamides B-D, depsipeptides from an Indonesian sponge that inhibit HIV-1 entry. | Q37131026 | ||
| Antiviral activity of human beta-defensin 3 against vaccinia virus | Q37156437 | ||
| Cationic host defence peptides: potential as antiviral therapeutics | Q37177085 | ||
| Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics | Q37230918 | ||
| Intrinsic amino acid side-chain hydrophilicity/hydrophobicity coefficients determined by reversed-phase high-performance liquid chromatography of model peptides: comparison with other hydrophilicity/hydrophobicity scales | Q37473836 | ||
| A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses | Q37507215 | ||
| Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization | Q37778090 | ||
| Targeting cell entry of enveloped viruses as an antiviral strategy. | Q37824811 | ||
| Therapeutic approaches using host defence peptides to tackle herpes virus infections | Q37945181 | ||
| Peptide inhibitors against herpes simplex virus infections. | Q38079780 | ||
| Surface plasmon resonance spectroscopy for characterisation of membrane protein-ligand interactions and its potential for drug discovery | Q38105839 | ||
| Bovine lactoferrin activity against Chikungunya and Zika viruses | Q38157919 | ||
| Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity | Q38208100 | ||
| Modulating protein-protein interactions: the potential of peptides | Q38314370 | ||
| Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan | Q38401839 | ||
| AVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses. | Q38490669 | ||
| Therapeutic peptides: Historical perspectives, current development trends, and future directions | Q38655677 | ||
| Discovery, structure, function, and applications of cyclotides: circular proteins from plants | Q38843873 | ||
| Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III. | Q39030086 | ||
| Application of modified yeast surface display technologies for non-Antibody protein engineering. | Q39121750 | ||
| Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus. | Q39193619 | ||
| Protegrin-1 inhibits dengue NS2B-NS3 serine protease and viral replication in MK2 cells | Q39254220 | ||
| Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus. | Q39341175 | ||
| Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication | Q39375601 | ||
| In vitro antiviral activity of dermaseptin S(4) and derivatives from amphibian skin against herpes simplex virus type 2. | Q39518387 | ||
| Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses. | Q39534646 | ||
| Studies of insect peptides alloferon, Any-GS and their analogues. Synthesis and antiherpes activity | Q39733886 | ||
| Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin | Q39936910 | ||
| Bovine Lactoferrin Inhibits Dengue Virus Infectivity by Interacting with Heparan Sulfate, Low-Density Lipoprotein Receptor, and DC-SIGN. | Q40039408 | ||
| In-vitro effect of human cathelicidin antimicrobial peptide LL-37 on dengue virus type 2. | Q40061463 | ||
| alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s). | Q40092958 | ||
| Cathelicidins display conserved direct antiviral activity towards rhinovirus | Q40099023 | ||
| The anti-papillomavirus activity of human and bovine lactoferricin | Q40136990 | ||
| Synthesis and disulfide bond connectivity-activity studies of a kalata B1-inspired cyclopeptide against dengue NS2B-NS3 protease | Q40369835 | ||
| Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study | Q40370597 | ||
| The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro | Q40444626 | ||
| Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus | Q40567499 | ||
| Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts | Q40795809 | ||
| Bovine Lactoferrampin, Human Lactoferricin, and Lactoferrin 1-11 Inhibit Nuclear Translocation of HIV Integrase | Q40829357 | ||
| Antimicrobial peptide LL-37 attenuates infection of hepatitis C virus | Q40895388 | ||
| Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression | Q41047045 | ||
| Antiviral activity of a Bacillus sp. P34 peptide against pathogenic viruses of domestic animals | Q41615651 | ||
| Bio-layer interferometry for measuring kinetics of protein-protein interactions and allosteric ligand effects. | Q42018301 | ||
| Insect Immunity. Purification and Properties of Three Inducible Bactericidal Proteins from Hemolymph of Immunized Pupae of Hyalophora cecropia | Q42077725 | ||
| Inhibitory activity and mechanism of two scorpion venom peptides against herpes simplex virus type 1. | Q42250486 | ||
| Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils. | Q42544979 | ||
| Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2. | Q42730622 | ||
| Systematic screening of viral entry inhibitors using surface plasmon resonance. | Q44105945 | ||
| A cyclotide against influenza A H1N1 virus from Viola yedoensis | Q44133633 | ||
| Structure-based engineering of a monoclonal antibody for improved solubility | Q44381771 | ||
| Homophymine A, an anti-HIV cyclodepsipeptide from the sponge Homophymia sp. | Q44894620 | ||
| Peptides as Therapeutic Agents for Dengue Virus | Q45323856 | ||
| The antimicrobial peptide HS-1 inhibits dengue virus infection. | Q45324623 | ||
| Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1. | Q45394217 | ||
| Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis. | Q46849544 | ||
| Biopanning of polypeptides binding to bovine ephemeral fever virus G1 protein from phage display peptide library | Q47170002 | ||
| Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1. | Q47171976 | ||
| Large-Scale Analysis of Antimicrobial Activities in Relation to Amphipathicity and Charge Reveals Novel Characterization of Antimicrobial Peptides | Q47324020 | ||
| Evaluation of sequence variability in HIV-1 gp41 C-peptide helix-grafted proteins | Q47792114 | ||
| Sesquin, a potent defensin-like antimicrobial peptide from ground beans with inhibitory activities toward tumor cells and HIV-1 reverse transcriptase. | Q50484442 | ||
| Litopenaeus vannamei attenuates white spot syndrome virus replication by specific antiviral peptides generated from hemocyanin | Q58552583 | ||
| Novel bioactive peptides demonstrating anti-dengue virus activity isolated from the Asian medicinal plant Acacia Catechu | Q59352453 | ||
| Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial-approved membrane fusion inhibitor | Q59358338 | ||
| Antiviral Activity of a Turbot () NK-Lysin Peptide by Inhibition of Low-pH Virus-Induced Membrane Fusion | Q63246515 | ||
| Synthetic surfactin analogues have improved anti-PEDV properties | Q64056978 | ||
| A Comprehensive Review on Current Advances in Peptide Drug Development and Design. | Q64993130 | ||
| Expression of human beta-defensin-2 and -3 in verrucae vulgares and condylomata acuminata | Q80921107 | ||
| Antimicrobial peptides | Q87078639 | ||
| Computationally Designed Peptides for Zika Virus Detection: An Incremental Construction Approach | Q90164445 | ||
| Clinical Applications of Antimicrobial Peptides (AMPs): Where do we Stand Now? | Q90276126 | ||
| Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections | Q91436588 | ||
| Molecular evolution of peptides by yeast surface display technology | Q91709541 | ||
| Antiviral activity of phage display-selected peptides against Japanese encephalitis virus infection in vitro and in vivo | Q91776613 | ||
| Predicting and designing therapeutics against the Nipah virus | Q91917203 | ||
| Antiviral activity of Piscidin 1 against pseudorabies virus both in vitro and in vivo | Q92318104 | ||
| In Vitro Selection of Peptides and Proteins-Advantages of mRNA Display | Q92350338 | ||
| Human Antimicrobial Peptides as Therapeutics for Viral Infections | Q92372793 | ||
| Helix-A peptide prevents gp120-mediated neuronal loss | Q93020714 | ||
| Antiviral activity and mode of action of a peptide isolated from Sorghum bicolor | Q94603434 | ||
| P304 | page(s) | 1-20 | |
| P577 | publication date | 2020-05-18 | |
| P1433 | published in | International Journal of Peptide Research and Therapeutics | Q15757092 |
| P1476 | title | Antiviral Peptides: Identification and Validation |
Search more.